HLA and susceptibility to cervical neoplasia

被引:70
作者
Krul, EJT
Schipper, RF
Schrueder, GMT
Fleuren, GJ
Kenter, GG
Melief, CJM
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Bloodbank, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Pathol, NL-2300 RC Leiden, Netherlands
[4] Leiden Univ, Med Ctr, Dept Gynecol, NL-2300 RC Leiden, Netherlands
关键词
cervical neoplasia; HLA; HPV;
D O I
10.1016/S0198-8859(98)00127-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The association between cervical neoplasia and certain HLA phenotypes observed in different studies has not been consistent. By serological typing, the association between HLA antigens, cervical carcinoma and cervical intraepithelial neoplasia (CIN) was studied in a group of 172 and 116 patients, respectively. We demonstrated an increased frequency of B63 in patients with HPV types other than HPV 16 or 18, and B55 in patients that were negative for all HPV types. The association between cervical carcinoma and DQ3, described in various populations, was not observed in the present study. However, we confirmed other previously observed associations between cervical cancer and class II antigens, i.e., a positive correlation with DR15 irrespective of the HPV status, with DR3 in patients harboring HPV types other than HPV 16 or 18, and with DR11 among HPV 16 positive patients. In contrast, a negative correlation between DR13 and HPV positive cervical cancer was observed which suggests protection of this antigen against HPV-associated cervical cancer. A slight increase of DR15 and DQ4 antigens was observed in CIN patients, suggesting that these specific HLA antigens may be important in determining the risk of GIN. Human Immunology 60, 337-342 (1999). (C) American Society for Histocompatibility and Immunogenetics, 1999. Published by Elsevier Science Inc.
引用
收藏
页码:337 / 342
页数:6
相关论文
共 37 条
[1]   HLA DQ-DR haplotype and susceptibility to cervical carcinoma: Indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18 [J].
Allen, M ;
Kalantari, M ;
Ylitalo, N ;
Pettersson, B ;
Hagmar, B ;
Scheibenpflug, L ;
Johansson, B ;
Petterson, U ;
Gyllensten, U .
TISSUE ANTIGENS, 1996, 48 (01) :32-37
[2]   HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN WITH RENAL-ALLOGRAFTS [J].
ALLOUB, MI ;
BARR, BBB ;
MCLAREN, KM ;
SMITH, IW ;
BUNNEY, MH ;
SMART, GE .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 298 (6667) :153-156
[3]   COMPARISON OF HUMAN-LEUKOCYTE ANTIGEN DR-DQ DISEASE ASSOCIATIONS FOUND WITH CERVICAL DYSPLASIA AND INVASIVE CERVICAL-CARCINOMA [J].
APPLE, RJ ;
BECKER, TM ;
WHEELER, CM ;
ERLICH, HA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (06) :427-436
[4]   HLA DR-DQ ASSOCIATIONS WITH CERVICAL-CARCINOMA SHOW PAPILLOMAVIRUS-TYPE SPECIFICITY [J].
APPLE, RJ ;
ERLICH, HA ;
KLITZ, W ;
MANOS, MM ;
BECKER, TM ;
WHEELER, CM .
NATURE GENETICS, 1994, 6 (02) :157-162
[5]  
BARR BBB, 1989, LANCET, V1, P124
[6]  
EDWARDS JH, 1974, J IMMUNOGENET, V1, P249
[7]  
Evans EML, 1997, CANCER RES, V57, P2943
[8]  
GARAU XS, 1996, INT J CANCER, V69, P159
[9]  
GLEW SS, 1993, HUM IMMUNOL, V37, P157, DOI 10.1016/0198-8859(93)90181-Y
[10]   ASSOCIATION BETWEEN HLA-DQB1 ALLELES AND RISK FOR CERVICAL-CANCER IN AFRICAN-AMERICAN WOMEN [J].
GREGOIRE, L ;
LAWRENCE, WD ;
KUKURUGA, D ;
EISENBREY, AB ;
LANCASTER, WD .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (04) :504-507